David L. Kaplan,Michael L. Lovett,Tuna Yucel,Xiaoqin Wang
申请号:
US15279186
公开号:
US20170173161A1
申请日:
2016.09.28
申请国别(地区):
US
年份:
2017
代理人:
摘要:
Embodiments of various aspects described herein are directed to silk-based compositions for ocular delivery of at least one active agent, e.g., at least one therapeutic agent and methods of using the same. In some embodiments, the silk-based compositions can provide sustained release of at least one therapeutic agent to at least a portion of an eye. Thus, some embodiments of the silk-based compositions can be used for treatment of an ocular condition, e.g., age-related macular degeneration.